Cancer drug therapy and stochastic modeling of “nano-motors”

Lubna Sherin,1 Shabieh Farwa,2 Ayesha Sohail,3 Zhiwu Li,4,5 O Anwar Bég6 1Department of Chemistry, COMSATS University Islamabad, Lahore 54000, Pakistan; 2Department of Mathematics, COMSATS University Islamabad, Wah Cantt, Pakistan; 3Department of Mathematics, COMSATS University Islamabad...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sherin L, Farwa S, Sohail A, Li Z, Bég OA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Eg5
Acceso en línea:https://doaj.org/article/8573dcd2576149f286b5b8a5f1e9ad22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8573dcd2576149f286b5b8a5f1e9ad22
record_format dspace
spelling oai:doaj.org-article:8573dcd2576149f286b5b8a5f1e9ad222021-12-02T07:24:02ZCancer drug therapy and stochastic modeling of “nano-motors”1178-2013https://doaj.org/article/8573dcd2576149f286b5b8a5f1e9ad222018-10-01T00:00:00Zhttps://www.dovepress.com/cancer-drug-therapy-and-stochastic-modeling-of-nano-motors-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Lubna Sherin,1 Shabieh Farwa,2 Ayesha Sohail,3 Zhiwu Li,4,5 O Anwar Bég6 1Department of Chemistry, COMSATS University Islamabad, Lahore 54000, Pakistan; 2Department of Mathematics, COMSATS University Islamabad, Wah Cantt, Pakistan; 3Department of Mathematics, COMSATS University Islamabad, Lahore 54000, Pakistan; 4Institute of Systems Engineering, Macau University of Science and Technology, Taipa, Macau; 5School of Electro-Mechanical Engineering, Xidian University, Xi’an 710071, China; 6Fluid Mechanics, Spray Research Group, Mechanical and Petroleum Engineering, School of Computing, Science and Engineering, G77, University of Salford, Manchester M54WT, UK Background: Controlled inhibition of kinesin motor proteins is highly desired in the field of oncology. Among other interventions, there exists “targeted chemotherapeutic regime/options” of selective Eg5 competitive and allosteric inhibitors, inducing cancer cell apoptosis and tumor regression with improved safety profiles. Research question: Though promising, such studies are still under clinical trials, for the discovery of efficient and least harmful Eg5 inhibitors. The aim of this research was to bridge the computational modeling approach with drug design and therapy of cancer cells. Methods: A computational model, interfaced with the clinical data of “Eg5 dynamics” and “inhibitors” via special functions, is presented in this article. Comparisons are made for the drug efficacy, and the threshold values are predicted through numerical simulations. Results: Results are obtained to depict the dynamics induced by ispinesib, when used as an inhibitor of kinesin Eg5, on cancer cell lines. Keywords: drug efficient model, bipolar spindle, Eg5, cancer, mitotic arrest, Eg5 inhibitorsSherin LFarwa SSohail ALi ZBég OADove Medical Pressarticledrug efficient modelbipolar spindleEg5cancermitotic arrestEg5 inhibitorsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 6429-6440 (2018)
institution DOAJ
collection DOAJ
language EN
topic drug efficient model
bipolar spindle
Eg5
cancer
mitotic arrest
Eg5 inhibitors
Medicine (General)
R5-920
spellingShingle drug efficient model
bipolar spindle
Eg5
cancer
mitotic arrest
Eg5 inhibitors
Medicine (General)
R5-920
Sherin L
Farwa S
Sohail A
Li Z
Bég OA
Cancer drug therapy and stochastic modeling of “nano-motors”
description Lubna Sherin,1 Shabieh Farwa,2 Ayesha Sohail,3 Zhiwu Li,4,5 O Anwar Bég6 1Department of Chemistry, COMSATS University Islamabad, Lahore 54000, Pakistan; 2Department of Mathematics, COMSATS University Islamabad, Wah Cantt, Pakistan; 3Department of Mathematics, COMSATS University Islamabad, Lahore 54000, Pakistan; 4Institute of Systems Engineering, Macau University of Science and Technology, Taipa, Macau; 5School of Electro-Mechanical Engineering, Xidian University, Xi’an 710071, China; 6Fluid Mechanics, Spray Research Group, Mechanical and Petroleum Engineering, School of Computing, Science and Engineering, G77, University of Salford, Manchester M54WT, UK Background: Controlled inhibition of kinesin motor proteins is highly desired in the field of oncology. Among other interventions, there exists “targeted chemotherapeutic regime/options” of selective Eg5 competitive and allosteric inhibitors, inducing cancer cell apoptosis and tumor regression with improved safety profiles. Research question: Though promising, such studies are still under clinical trials, for the discovery of efficient and least harmful Eg5 inhibitors. The aim of this research was to bridge the computational modeling approach with drug design and therapy of cancer cells. Methods: A computational model, interfaced with the clinical data of “Eg5 dynamics” and “inhibitors” via special functions, is presented in this article. Comparisons are made for the drug efficacy, and the threshold values are predicted through numerical simulations. Results: Results are obtained to depict the dynamics induced by ispinesib, when used as an inhibitor of kinesin Eg5, on cancer cell lines. Keywords: drug efficient model, bipolar spindle, Eg5, cancer, mitotic arrest, Eg5 inhibitors
format article
author Sherin L
Farwa S
Sohail A
Li Z
Bég OA
author_facet Sherin L
Farwa S
Sohail A
Li Z
Bég OA
author_sort Sherin L
title Cancer drug therapy and stochastic modeling of “nano-motors”
title_short Cancer drug therapy and stochastic modeling of “nano-motors”
title_full Cancer drug therapy and stochastic modeling of “nano-motors”
title_fullStr Cancer drug therapy and stochastic modeling of “nano-motors”
title_full_unstemmed Cancer drug therapy and stochastic modeling of “nano-motors”
title_sort cancer drug therapy and stochastic modeling of “nano-motors”
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/8573dcd2576149f286b5b8a5f1e9ad22
work_keys_str_mv AT sherinl cancerdrugtherapyandstochasticmodelingofldquonanomotorsrdquo
AT farwas cancerdrugtherapyandstochasticmodelingofldquonanomotorsrdquo
AT sohaila cancerdrugtherapyandstochasticmodelingofldquonanomotorsrdquo
AT liz cancerdrugtherapyandstochasticmodelingofldquonanomotorsrdquo
AT begoa cancerdrugtherapyandstochasticmodelingofldquonanomotorsrdquo
_version_ 1718399463604617216